Filing Details

Accession Number:
0001415889-24-002684
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-05 18:44:15
Reporting Period:
2024-02-01
Accepted Time:
2024-02-05 18:44:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1350653 Alphatec Holdings Inc. ATEC Surgical & Medical Instruments & Apparatus (3841) 202463898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1831608 Scott Lish C/O Alphatec Spine, Inc.
1950 Camino Vida Roble
Carlsbad CA 92008
Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-01 100,166 $0.00 543,667 No 4 A Direct
Common Stock Disposition 2024-02-02 25,210 $16.47 518,457 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. On February 1, 2024, the issuer awarded 100,166 restricted stock units (RSUs) to the reporting person upon confirmation by the issuer's compensation committee of satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. The RSUs vest in three equal installments on each of February 1, 2024, February 1, 2025 and February 1, 2026. Each RSU represents a contingent right to receive one share of the issuer's common stock.
  2. Includes 2,410 shares acquired under the issuer's employee stock purchase plan on June 20, 2023.
  3. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2022, as amended on August 10, 2023, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.29 to $16.78, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.